Daniel Daneshvar, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Football | 29 | 2024 | 503 | 4.490 |
Why?
|
Brain Concussion | 27 | 2024 | 1404 | 3.550 |
Why?
|
Athletic Injuries | 25 | 2024 | 1216 | 2.870 |
Why?
|
Sports Medicine | 9 | 2016 | 240 | 1.490 |
Why?
|
Brain Injury, Chronic | 10 | 2016 | 68 | 1.360 |
Why?
|
Athletes | 15 | 2023 | 1137 | 1.050 |
Why?
|
Tauopathies | 4 | 2023 | 320 | 1.000 |
Why?
|
Neurodegenerative Diseases | 6 | 2024 | 1088 | 0.740 |
Why?
|
Head Protective Devices | 2 | 2011 | 118 | 0.670 |
Why?
|
Brain | 31 | 2024 | 27120 | 0.670 |
Why?
|
Universities | 7 | 2016 | 993 | 0.600 |
Why?
|
Health Knowledge, Attitudes, Practice | 7 | 2021 | 4016 | 0.580 |
Why?
|
Hockey | 5 | 2024 | 96 | 0.570 |
Why?
|
Sports | 7 | 2024 | 705 | 0.520 |
Why?
|
Education, Continuing | 1 | 2016 | 114 | 0.510 |
Why?
|
tau Proteins | 16 | 2024 | 2095 | 0.500 |
Why?
|
Health Education | 5 | 2015 | 1052 | 0.500 |
Why?
|
Safety | 3 | 2015 | 1150 | 0.440 |
Why?
|
Brain Injuries | 5 | 2022 | 2053 | 0.430 |
Why?
|
Behavior | 1 | 2015 | 541 | 0.390 |
Why?
|
Mouth Protectors | 1 | 2011 | 6 | 0.380 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2021 | 1469 | 0.360 |
Why?
|
Intention | 4 | 2021 | 347 | 0.350 |
Why?
|
Lewy Body Disease | 2 | 2023 | 252 | 0.310 |
Why?
|
Alzheimer Disease | 9 | 2024 | 8601 | 0.280 |
Why?
|
Apathy | 2 | 2017 | 107 | 0.260 |
Why?
|
Autopsy | 3 | 2024 | 1009 | 0.220 |
Why?
|
Male | 50 | 2024 | 360842 | 0.220 |
Why?
|
Humans | 70 | 2024 | 761572 | 0.210 |
Why?
|
Executive Function | 3 | 2017 | 1392 | 0.210 |
Why?
|
Substantia Nigra | 1 | 2024 | 350 | 0.210 |
Why?
|
Encephalitis | 2 | 2016 | 438 | 0.200 |
Why?
|
Neurofibrillary Tangles | 3 | 2024 | 457 | 0.200 |
Why?
|
Carbolines | 1 | 2023 | 296 | 0.190 |
Why?
|
Soccer | 1 | 2023 | 142 | 0.190 |
Why?
|
Parkinsonian Disorders | 1 | 2024 | 284 | 0.190 |
Why?
|
Journal Impact Factor | 1 | 2022 | 153 | 0.190 |
Why?
|
Communication | 1 | 2015 | 3873 | 0.180 |
Why?
|
Pleasure | 1 | 2021 | 41 | 0.180 |
Why?
|
Motor Neuron Disease | 2 | 2011 | 97 | 0.180 |
Why?
|
Aggression | 1 | 2024 | 750 | 0.170 |
Why?
|
Australia | 1 | 2023 | 1250 | 0.160 |
Why?
|
Chemokine CCL11 | 1 | 2017 | 128 | 0.150 |
Why?
|
United States | 13 | 2024 | 72335 | 0.140 |
Why?
|
Canada | 1 | 2023 | 2122 | 0.140 |
Why?
|
Craniocerebral Trauma | 1 | 2021 | 490 | 0.140 |
Why?
|
Cattle | 1 | 2023 | 3849 | 0.140 |
Why?
|
Aged | 29 | 2024 | 169310 | 0.140 |
Why?
|
Terminology as Topic | 1 | 2024 | 1530 | 0.140 |
Why?
|
Middle Aged | 31 | 2024 | 220920 | 0.140 |
Why?
|
Cognition Disorders | 4 | 2017 | 3980 | 0.140 |
Why?
|
Neuropsychological Tests | 5 | 2024 | 7054 | 0.130 |
Why?
|
Plaque, Amyloid | 2 | 2018 | 760 | 0.130 |
Why?
|
Cognitive Reserve | 1 | 2016 | 92 | 0.130 |
Why?
|
Depression | 3 | 2024 | 8124 | 0.130 |
Why?
|
Logistic Models | 3 | 2021 | 13255 | 0.130 |
Why?
|
Neurons | 1 | 2015 | 9463 | 0.130 |
Why?
|
Behavioral Symptoms | 2 | 2016 | 186 | 0.130 |
Why?
|
Mental Disorders | 3 | 2024 | 6845 | 0.120 |
Why?
|
Schools | 2 | 2021 | 1489 | 0.120 |
Why?
|
Age Factors | 7 | 2024 | 18398 | 0.110 |
Why?
|
Head Injuries, Closed | 1 | 2014 | 133 | 0.110 |
Why?
|
Adult | 26 | 2024 | 221203 | 0.110 |
Why?
|
Cross-Sectional Studies | 8 | 2024 | 26127 | 0.110 |
Why?
|
Videotape Recording | 1 | 2014 | 337 | 0.100 |
Why?
|
Psychological Theory | 1 | 2014 | 175 | 0.100 |
Why?
|
Glasgow Coma Scale | 1 | 2015 | 580 | 0.100 |
Why?
|
Organizational Policy | 1 | 2014 | 432 | 0.100 |
Why?
|
Suicide | 1 | 2023 | 1601 | 0.100 |
Why?
|
Lewy Bodies | 2 | 2024 | 145 | 0.090 |
Why?
|
Adolescent | 12 | 2023 | 88324 | 0.090 |
Why?
|
TDP-43 Proteinopathies | 1 | 2010 | 38 | 0.090 |
Why?
|
Magnetic Resonance Imaging | 5 | 2024 | 36429 | 0.090 |
Why?
|
Young Adult | 13 | 2024 | 59255 | 0.090 |
Why?
|
Frontal Lobe | 1 | 2016 | 1420 | 0.090 |
Why?
|
Amyloid beta-Peptides | 3 | 2023 | 3839 | 0.080 |
Why?
|
Odds Ratio | 1 | 2021 | 9646 | 0.080 |
Why?
|
Anxiety | 1 | 2024 | 4573 | 0.080 |
Why?
|
Substance-Related Disorders | 2 | 2024 | 4420 | 0.080 |
Why?
|
DNA-Binding Proteins | 3 | 2023 | 9610 | 0.080 |
Why?
|
Cost-Benefit Analysis | 1 | 2022 | 5492 | 0.080 |
Why?
|
Post-Concussion Syndrome | 1 | 2011 | 243 | 0.080 |
Why?
|
Apolipoproteins E | 3 | 2022 | 1444 | 0.080 |
Why?
|
Risk Factors | 6 | 2024 | 74213 | 0.080 |
Why?
|
Self Report | 2 | 2016 | 3725 | 0.070 |
Why?
|
Microglia | 1 | 2016 | 1361 | 0.070 |
Why?
|
Spinal Cord | 1 | 2015 | 1819 | 0.070 |
Why?
|
Case-Control Studies | 2 | 2021 | 22176 | 0.070 |
Why?
|
Aged, 80 and over | 11 | 2024 | 58986 | 0.070 |
Why?
|
Retrospective Studies | 8 | 2024 | 80646 | 0.070 |
Why?
|
Self-Help Groups | 1 | 2008 | 192 | 0.070 |
Why?
|
Attitude to Health | 1 | 2014 | 2025 | 0.060 |
Why?
|
Sex Characteristics | 1 | 2015 | 2639 | 0.060 |
Why?
|
Pilot Projects | 2 | 2015 | 8633 | 0.060 |
Why?
|
Guideline Adherence | 1 | 2014 | 2220 | 0.060 |
Why?
|
Registries | 1 | 2019 | 8224 | 0.050 |
Why?
|
Female | 15 | 2024 | 392686 | 0.050 |
Why?
|
Incidence | 1 | 2021 | 21355 | 0.050 |
Why?
|
Severity of Illness Index | 5 | 2020 | 15843 | 0.050 |
Why?
|
Dementia | 1 | 2018 | 2689 | 0.050 |
Why?
|
Single-Blind Method | 2 | 2019 | 1574 | 0.050 |
Why?
|
Equipment Design | 1 | 2011 | 3511 | 0.050 |
Why?
|
Animals | 4 | 2023 | 168467 | 0.050 |
Why?
|
Automobile Driving | 1 | 2008 | 441 | 0.050 |
Why?
|
Prospective Studies | 4 | 2021 | 54426 | 0.050 |
Why?
|
Cognition | 4 | 2024 | 6992 | 0.050 |
Why?
|
Students | 3 | 2016 | 1741 | 0.050 |
Why?
|
Time Factors | 3 | 2024 | 39970 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39107 | 0.040 |
Why?
|
Activities of Daily Living | 2 | 2024 | 2421 | 0.040 |
Why?
|
Interviews as Topic | 2 | 2016 | 2696 | 0.040 |
Why?
|
Parkinson Disease | 1 | 2011 | 2877 | 0.040 |
Why?
|
Positron-Emission Tomography | 2 | 2023 | 6485 | 0.040 |
Why?
|
Trauma Severity Indices | 1 | 2018 | 478 | 0.030 |
Why?
|
Atrophy | 1 | 2021 | 1633 | 0.030 |
Why?
|
Cohort Studies | 5 | 2018 | 41493 | 0.030 |
Why?
|
Caregivers | 1 | 2008 | 2238 | 0.030 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2016 | 283 | 0.030 |
Why?
|
Tissue Donors | 1 | 2024 | 2332 | 0.030 |
Why?
|
Occupations | 1 | 2016 | 515 | 0.030 |
Why?
|
Genotype | 2 | 2022 | 12990 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2024 | 3208 | 0.030 |
Why?
|
Organizations | 1 | 2014 | 171 | 0.030 |
Why?
|
Teaching Materials | 1 | 2013 | 84 | 0.030 |
Why?
|
Mandatory Reporting | 1 | 2014 | 123 | 0.030 |
Why?
|
Cell Count | 1 | 2016 | 1835 | 0.030 |
Why?
|
Mental Processes | 1 | 2013 | 244 | 0.020 |
Why?
|
alpha-Synuclein | 1 | 2018 | 750 | 0.020 |
Why?
|
Endocarditis, Bacterial | 1 | 2016 | 436 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2016 | 1835 | 0.020 |
Why?
|
Health Status | 1 | 2024 | 4077 | 0.020 |
Why?
|
Apolipoprotein E4 | 1 | 2015 | 709 | 0.020 |
Why?
|
Interview, Psychological | 1 | 2013 | 809 | 0.020 |
Why?
|
Veterans | 2 | 2015 | 2649 | 0.020 |
Why?
|
Self Efficacy | 1 | 2014 | 638 | 0.020 |
Why?
|
Judgment | 1 | 2012 | 273 | 0.020 |
Why?
|
Guidelines as Topic | 1 | 2016 | 1386 | 0.020 |
Why?
|
Age of Onset | 1 | 2016 | 3306 | 0.020 |
Why?
|
Risk Assessment | 1 | 2011 | 23996 | 0.020 |
Why?
|
Interprofessional Relations | 1 | 2015 | 990 | 0.020 |
Why?
|
Mental Health | 1 | 2023 | 3250 | 0.020 |
Why?
|
Educational Status | 1 | 2016 | 2522 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2016 | 14607 | 0.020 |
Why?
|
Video Recording | 1 | 2013 | 967 | 0.020 |
Why?
|
Perception | 1 | 2014 | 1197 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2016 | 15266 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2014 | 2426 | 0.020 |
Why?
|
Regression Analysis | 1 | 2016 | 6344 | 0.020 |
Why?
|
Staphylococcal Infections | 1 | 2016 | 1407 | 0.020 |
Why?
|
Memory, Short-Term | 1 | 2013 | 982 | 0.020 |
Why?
|
Cause of Death | 1 | 2017 | 3683 | 0.020 |
Why?
|
Microscopy | 1 | 2011 | 903 | 0.020 |
Why?
|
Linear Models | 1 | 2016 | 5872 | 0.020 |
Why?
|
Military Personnel | 1 | 2015 | 1246 | 0.020 |
Why?
|
Forecasting | 1 | 2015 | 2928 | 0.020 |
Why?
|
Antigens, CD | 1 | 2016 | 4001 | 0.020 |
Why?
|
Disease Progression | 2 | 2013 | 13510 | 0.020 |
Why?
|
Heart Arrest | 1 | 2016 | 1514 | 0.020 |
Why?
|
Consensus | 1 | 2015 | 3123 | 0.020 |
Why?
|
Family | 1 | 2016 | 3194 | 0.020 |
Why?
|
Psychomotor Performance | 1 | 2013 | 1882 | 0.020 |
Why?
|
ROC Curve | 1 | 2012 | 3579 | 0.010 |
Why?
|
Recurrence | 1 | 2016 | 8466 | 0.010 |
Why?
|
Visual Perception | 1 | 2012 | 1389 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2016 | 7827 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2015 | 11076 | 0.010 |
Why?
|
Attitude of Health Personnel | 1 | 2015 | 3889 | 0.010 |
Why?
|
Emotions | 1 | 2013 | 2739 | 0.010 |
Why?
|
Comorbidity | 1 | 2015 | 10508 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2018 | 15936 | 0.010 |
Why?
|
Sex Factors | 1 | 2011 | 10553 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2012 | 14666 | 0.010 |
Why?
|
Child | 2 | 2015 | 80156 | 0.010 |
Why?
|
Aging | 1 | 2013 | 8711 | 0.010 |
Why?
|
Curriculum | 1 | 2008 | 3743 | 0.010 |
Why?
|
Decision Making | 1 | 2008 | 3929 | 0.010 |
Why?
|
Stress, Psychological | 1 | 2008 | 4481 | 0.010 |
Why?
|